Insulin Degludec/Liraglutide (Xultophy 100/3.6) for Type 2 Diabetes

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2017年 / 59卷 / 1529期
关键词：
FIXED-RATIO COMBINATION; LIRAGLUTIDE IDEGLIRA; EFFICACY; OUTCOMES; DEGLUDEC; TRIAL;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：147 / 149
页数：3
相关论文
共 50 条
  • [41] Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide
    Vedtofte, Louise
    Knop, Filip K.
    Vilsboll, Tina
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (03) : 273 - 282
  • [42] Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysis
    Cai, Xiaoling
    Gao, Xueying
    Yang, Wenjia
    Ji, Linong
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (17) : 1789 - 1798
  • [43] In patients with Type 2 diabetes, treatment with IDegLira, a combination of insulin degludec and liraglutide, improves both preprandial and postprandial plasma glucose
    Viljoen, A.
    King, A.
    Philis-Tsimikas, A.
    Langbakke, I. H.
    Kvist, K.
    Vilsboll, T.
    DIABETIC MEDICINE, 2015, 32 : 74 - 74
  • [44] HDL LIPIDOMIC ANALYSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS RECEIVING FIXED-DOSE COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE
    Pappa, E.
    Vavli, E.
    Kostara, C.
    Bairaktari, E.
    Tsimihodimos, V.
    ATHEROSCLEROSIS, 2020, 315 : E65 - E65
  • [45] Insulin degludec - The impact of a new basal insulin on care in type 2 diabetes
    Khunti, Kamlesh
    Cos, Xavier
    Rutten, Guy
    PRIMARY CARE DIABETES, 2014, 8 (02) : 119 - 125
  • [46] EFFECT OF THE FIXED-DOSE COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE ON SERUM LIPOPROTEIN METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Pappa, E.
    Arvaniti, E.
    Dimou, A.
    Kostara, C.
    Tellis, K.
    Tselepis, A.
    Bairaktari, E.
    Elisaf, M.
    Tsimihodimos, V.
    ATHEROSCLEROSIS, 2019, 287 : E127 - E128
  • [47] The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus
    Pappa, Eleni
    Kostara, Christina
    Tellis, Constantinos
    Tselepis, Alexandros D.
    Bairaktari, Eleni
    Tsimihodimos, Vasilis
    DIABETES, 2020, 69
  • [48] IDegLira, a combination of insulin degludec and liraglutide, improves both pre- and postprandial plasma glucose in patients with type 2 diabetes
    King, A.
    Philis-Tsimikas, A.
    Langbakke, I. H.
    Kvist, K.
    Vilsboll, T.
    DIABETOLOGIA, 2014, 57 : S108 - S109
  • [49] Real-world use of insulin degludec/liraglutide (IDegLira) significantly improves glycaemic control in patients with Type 2 diabetes
    Feher, M.
    Price, H.
    Schultes, B.
    Prager, R.
    Phan, T. M.
    Thorsted, B. L.
    Bluher, M.
    DIABETIC MEDICINE, 2018, 35 : 158 - 158
  • [50] Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy
    Kumar, Ajay
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (06) : 869 - 878
12345